Visiongain Report Looks at Opportunities within the $75bn Vaccines Sales Market

Global Vaccines Sales Market Forecast 2019-2029

Paediatric Vaccines, Adult Vaccines, Elderly Vaccines, Travel Vaccines, Therapeutic Vaccines, Prevnar, Gardasil, Fluzone, Pentacel, ProQuad, Infanrix/Pediarix, Zostavax, RotaTeq, Menactra

News provided by

Sep 04, 2019, 05:00 ET

LONDON, Sept. 4, 2019 /PRNewswire/ -- The global vaccines market is estimated at $41bn in 2018 and is expected to grow at a CAGR of 10.9% during the forecast period. The Paediatric Vaccines segment held 56% of the Global Vaccines market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 121 charts– all unavailable elsewhere.

The 201-page report provides clear detailed insight into the global vaccines sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-vaccines-sales-market-forecast-2019-2029/#download_sampe_div

Report Scope

• Global Vaccines Sales Market forecasts from 2019-2029

• Global Vaccines Sales Market forecasts from 2019-2029 by Submarket:
• Paediatric Vaccines
• Adult Vaccines
• Elderly Vaccines
• Travel Vaccines
• Therapeutic Vaccines

• Global Vaccines Sales Market forecasts from 2019-2029 by Leading Vaccines:
• Prevnar
• Gardasil
• Fluzone
• Pentacel
• ProQuad
• Infanrix/Pediarix
• Zostavax
• RotaTeq
• Hepatitis Vaccines
• Menactra

• Global Vaccines Sales Market forecasts from 2019-2029 by Regional and National Market:
• US
• EU5: Germany, France, Italy, UK, Spain
• Japan
• Brazil
• Russia
• India
• China

• Profiles of the selected leading companies:
• AstraZeneca
• Eli Lilly
• Emergent BioSolutions Inc.
• GlaxoSmithKline
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Sanofi
• Serum Indian Institute Pvt. Ltd.
• Takeda

• The Vaccines Market Pipeline Analysis

• A SWOT and STEP analysis of the global vaccines market

• Key Questions Answered by this Report:
• What is the current size of the overall global human vaccines market? How much will this market be worth from 2018 to 2029?
• What are the main drivers and restraints that will shape the overall vaccines market over the next ten years?
• What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2018 to 2029? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2028?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2029, and which geographical region will lead the market in 2029?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are the leading vaccines? What are their revenues and latest developments?
• What are some of the most prominent human vaccines currently in development?
• What are the main trends that will affect the world vaccines market between 2018 and 2029?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global vaccines market evolve over the forecasted period, 2018 to 2029?
• How will the market shares for each checkpoint inhibitor anti-cancer treatment submarket develop from 2018 to 2029?
• Which therapies can succeed and what revenues could they generate to 2029?
• What will be the main commercial drivers for the market from 2018 to 2029?
• How will market shares of prominent national markets change from 2018, and which countries will lead the market in 2029, achieving highest revenues and fastest growth?
• How will that industry evolve between 2018 and 2029, especially in R&D?

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-vaccines-sales-market-forecast-2019-2029/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

AstraZeneca
Bavarian Nordic
Bayer
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL)
Binnopharm
BiondVax
Bristol-Myers Squibb
Chemo-Sero-Therapeutic Research Institute
China National Biotec Group
Denka Seiken
Eli Lilly
Emergent BioSolutions Inc
Fresenius
GlaxoSmithKline (GSK)
GlaxoWellcome
Henogen
Immatics
InterveXion Therapeutics
Johnson & Johnson
LigoCyte
MedImmune
Merck & Co.
Merck Sharp & Dohme Corp
Nanolek
NewLink Genetics
Okairos
PaxVax
Pfizer
Protein Science
Roche
Sanofi Pasteur
Serum Indian Institute Pvt. Ltd.
SmithKline Beecham
Takeda
Themis Bioscience

Organizations Mentioned in the Report
Centers for Disease Control and Protection (CDC)
Centre for Biologics Evaluation and Research (CBER)
Developing Countries Vaccine Manufacturers Network (DCVMN)
European Medicines Agency (EMA)
Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Food and Drug Administration (FDA)
Global Alliance for Vaccines
Global Alliance for Vaccines and Immunization (GAVI)
International Financing Facility for Immunisation
National Health Service (NHS)
Pan American Health Organization (PAHO)
The Butantan Institute
The Indian Department of Biotech
The Ministry of Health, Labour and Welfare and the Health Service Bureau
UNICEF
World Health Organization (WHO)